Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion type Assertion NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_head.
- NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion description "[As the VEGFR has an important impact on the pathogenesis of JNA, we suggest that a targeted therapy with monoclonal antibodies against VEGFR might lead to a specific chemoprevention and treatment of these tumors and their recurrences.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_provenance.
- NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion evidence source_evidence_literature NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_provenance.
- NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion SIO_000772 18227724 NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_provenance.
- NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion wasDerivedFrom befree-20140225 NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_provenance.
- NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_assertion wasGeneratedBy ECO_0000203 NP789528.RAmbNbFTLImDKlENqvvdqF1hd6kbmojXCRXSNT1rHvTCc130_provenance.